LifeStance Health (LFST) Receivables (2020 - 2026)

LifeStance Health (LFST) has 7 years of Receivables data on file, last reported at $122.9 million in Q1 2026.

• Quarterly Receivables fell 12.43% year-over-year to $122.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.9 million (down 12.43% YoY) and the FY2025 annual result came in at $99.5 million, down 24.64% from the prior year.
• Receivables rose to $122.9 million in Q1 2026 per LFST's latest filing, from $99.5 million in the prior quarter.
• Across five years, Receivables topped out at $175.9 million in Q1 2024 and bottomed at $95.0 million in Q1 2022.
• The 5-year median for Receivables is $122.9 million (2026), against an average of $127.7 million.
• The widest annual swing landed in 2022, when Receivables surged 54.47%; it then fell 24.64% in 2025.
• Tracing LFST's Receivables over 5 years: stood at $101.5 million in 2022, then climbed by 23.77% to $125.6 million in 2023, then grew by 5.08% to $132.0 million in 2024, then slipped by 24.64% to $99.5 million in 2025, then climbed by 23.53% to $122.9 million in 2026.
• Per Business Quant, the three latest LFST Receivables figures stand at $122.9 million (Q1 2026), $99.5 million (Q4 2025), and $121.1 million (Q3 2025).

Peer Comparison